Nicotine and cancer

Alcohol, Tobacco and Cancer

Volumn , Issue , 2006, Pages 253-267

  Wu, William Ka Kei ^a   Wong, Helen Pui Shan ^a   Yu, Le ^a   Cho, Chi Hin ^a,b  

^a Department of Pharmacology ^*  (China)

^b Center for Health Behaviours Research School of Public Health and Primary Care Faculty of Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60349106079     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000095077     Document Type: Chapter

References (75)

1. International Agency for Research on Cancer (IARC): Tobacco smoking; in IARC Monographs onthe Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon, France, IARC, 1986, vol 38.
2. International Agency for Research on Cancer (IARC): Tobacco smoking and tobacco smoke; inIARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon,France, IARC, 2002, vol 83.
3. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-1210.
4. Benowitz NL: Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.N Engl J Med 1988;319:1318-1330.
5. Henningfield JE: Nicotine medications for smoking cessation. N Engl J Med 1995;333:1196-1203.
6. Lindell G, Farnebo LO, Chen D, Nexo E, Rask Madsen J, Bukhave K, Graffner H: Acute effects ofsmoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acidsecretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids.Scand J Gastroenterol 1993;28:487-494.
7. Jones RW: Have cholinergic therapies reached their clinical boundary in Alzheimer's disease? IntJ Geriatr Psychiatry 2003;18(suppl 1):S7-S13.
8. Quik M, Kulak JM: Nicotine and nicotinic receptors; relevance to Parkinson's disease.Neurotoxicology 2002;23:581-594.
9. Picciotto MR, Brunzell DH, Caldarone BJ: Effect of nicotine and nicotinic receptors on anxietyand depression. Neuroreport 2002;13:1097-1106.
10. Sanberg PR, Silver AA, Shytle RD, Philipp MK, Cahill DW, Fogelson HM, McConville BJ:Nicotine for the treatment of Tourette's syndrome. Pharmacol Ther 1997;74:21-25.
11. Marlow SP, Stoller JK: Smoking cessation. Respir Care 2003;48:1238-1254; discussion 1254-1256.
12. Birrenbach T, Bocker U: Inflammatory bowel disease and smoking: a review of epidemiology,pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004;10:848-859.
13. Wright SC, Zhong J, Zheng H, Larrick JW: Nicotine inhibition of apoptosis suggests a role intumor promotion. FASEB J 1993;7:1045-1051.
14. Garnier M, Lamacz M, Tonon MC, Vaudry H: Functional characterization of a nonclassical nico-tine receptor associated with inositolphospholipid breakdown and mobilization of intracellularcalcium pools. Proc Natl Acad Sci USA 1994;91:11743-11747.
15. Sargent PB: The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci1993;16:403-443.
16. Rathouz MM, Vijayaraghavan S, Berg DK: Elevation of intracellular calcium levels in neurons bynicotinic acetylcholine receptors. Mol Neurobiol 1996;12:117-131.
17. Hecht SS: Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer2003;3:733-744.
18. Clarke PB: Nicotine dependence - mechanisms and therapeutic strategies. Biochem Soc Symp1993;59:83-95.
19. Riebe M, Westphal K: Studies on the induction of sisterchromatid exchanges in Chinese hamsterovary cells by various tobacco alkaloids. Mutat Res 1983;124:281-286.
20. Trivedi AH, Dave BJ, Adhvaryu SG: Assessment of genotoxicity of nicotine employing in vitromammalian test system. Cancer Lett 1990;54:89-94.
21. Argentin G, Cicchetti R: Genotoxic and antiapoptotic effect of nicotine on human gingival fibrob-lasts. Toxicol Sci 2004;79:75-81.
22. Cook JC, Klinefelter GR, Hardisty JF, Sharpe RM, Foster PM: Rodent Leydig cell tumorigenesis:a review of the physiology, pathology, mechanisms, and relevance to humans. Crit Rev Toxicol1999;29:169-261.
23. Li XS, Wang HF, Shi JY, et al: Genotoxicity study on nicotine and nicotine-derived nitrosamine byaccelerator mass spectrometry. Radiocarbon 1996;38:347-353.
24. Wu XH, Wang HF, Liu YF, Lu XY, Wang JJ, Li K: Histone adduction with nicotine: a bio-AMSstudy. Radiocarbon 1997;39:293-297.
25. Yim SH, Hee SS: Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mix-tures. Mutat Res 2001;492:13-27.
26. Yim SH, Hee SS: Genotoxicity of nicotine and cotinine in the bacterial luminescence test. MutatRes 1995;335:275-283.
27. Hecht SS, Hochalter JB, Villalta PW, Murphy SE: 2'-Hydroxylation of nicotine by cytochromeP450 2A6 and human liver microsomes: formation of a lung carcinogen precursor. Proc Natl AcadSci USA 2000;97:12493-12497.
28. Carmella SG, Borukhova A, Desai D, Hecht SS: Evidence for endogenous formation of tobacco-specific nitrosamines in rats treated with tobacco alkaloids and sodium nitrite. Carcinogenesis1997;18:587-592.
29. Hecht SS, Carmella SG, Chen M, Dor Koch JF, Miller AT, Murphy SE, Jensen JA, Zimmerman CL,Hatsukami DK: Quantitation of urinary metabolites of a tobacco-specific lung carcinogen aftersmoking cessation. Cancer Res 1999;59:590-596.
30. Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck BE Jr, Ihde DC, Bunn PA Jr,Matthews MJ, Makuch R: Smoking abstinence and small cell lung cancer survival. An association.JAMA 1980;244:2175-2179.
31. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN:Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993;328:159-163.
32. Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, Vincent MD, Yu EW: Continuedcigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-celllung cancer is associated with decreased survival. J Clin Oncol 2003;21:1544-1549.
33. Cattaneo MG, Codignola A, Vicentini LM, Clementi F, Sher E: Nicotine stimulates a serotonergicautocrine loop in human small-cell lung carcinoma. Cancer Res 1993;53:5566-5568.
34. Ye YN, Liu ES, Shin VY, Wu WK, Luo JC, Cho CH: Nicotine promoted colon cancer growthviaepidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther 2004;308:66-72.
35. Shin VY, Wu WK, Ye YN, So WH, Koo MW, Liu ES, Luo JC, Cho CH: Nicotine promotes gastrictumor growth and neovascularization by activating extracellular signal-regulated kinase andcyclooxygenase-2. Carcinogenesis 2004;25:2487-2495.
36. Bose C, Zhang H, Udupa KB, Chowdhury P: Activation of p-ERK1/2 by nicotine in pancreatictumor cell line AR42J: effects on proliferation and secretion. Am J Physiol Gastrointest LiverPhysiol 2005;289:G926-G934.
37. Waggoner SE, Wang X: Effect of nicotine on proliferation of normal, malignant, and humanpapillomavirus-transformed human cervical cells. Gynecol Oncol 1994;55:91-95.
38. Trombino S, Cesario A, Margaritora S, Granone P, Motta G, Falugi C, Russo P: Alpha7-nicotinicacetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res 2004;64:135-145.
39. Fang MA, Frost PJ, Iida-Klein A, Hahn TJ: Effects of nicotine on cellular function in UMR106-01 osteoblast-like cells. Bone 1991;12:283-286.
40. Cheng YA, Shiue LF, Yu HS, Hsieh TY, Tsai CC: Interleukin-8 secretion by cultured oral epider-moid carcinoma cells induced with nicotine and/or arecoline treatments. Kaohsiung J Med Sci2000;16:126-133.
41. Villablanca AC: Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cellsin vitro. J Appl Physiol 1998;84:2089-2098.
42. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, Cooke JP: Nicotinestimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001;7:833-839.
43. Codignola A, Tarroni P, Cattaneo MG, Vicentini LM, Clementi F, Sher E: Serotonin release andcell proliferation are under the control of alpha-bungarotoxin-sensitive nicotinic receptors insmall-cell lung carcinoma cell lines. FEBS Lett 1994;342:286-290.
44. Tsurutani J, Castillo SS, Brognard J, Granville CA, Zhang C, Gills JJ, Sayyah J, Dennis PA:Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival inlung cancer cells. Carcinogenesis 2005;26:1182-1195.
45. Maneckjee R, Minna JD: Opioid and nicotine receptors affect growth regulation of human lungcancer cell lines. Proc Natl Acad Sci USA 1990;87:3294-3298.
46. Song P, Sekhon HS, Jia Y, Keller JA, Blusztajn JK, Mark GP, Spindel ER: Acetylcholine is syn-thesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res2003;63:214-221.
47. Gurkalo VK, Volfson NI: Nicotine influence upon the development of experimental stomachtumors. Arch Geschwulstforsch 1982;52:259-265.
48. Backlund MG, Mann JR, Dubois RN: Mechanisms for the prevention of gastrointestinal cancer:the role of prostaglandin E2. Oncology 2005;69(suppl 1):28-32.
49. Rakowicz-Szulczynska EM, McIntosh DG, Perry M, Smith ML: PDGF AA as mediator in nico-tine-dependent carcinogenesis. Carcinogenesis 1996;17:1813-1818.
50. Mathur RS, Mathur SP, Young RC: Up-regulation of epidermal growth factor-receptors (EGF-R)by nicotine in cervical cancer cell lines: this effect may be mediated by EGF. Am J ReprodImmunol 2000;44:114-120.
51. Lane D, Gray EA, Mathur RS, Mathur SP: Up-regulation of vascular endothelial growth factor-Cby nicotine in cervical cancer cell lines. Am J Reprod Immunol 2005;53:153-158.
52. Schuller HM, Cole B: Regulation of cell proliferation by beta-adrenergic receptors in a humanlung adenocarcinoma cell line. Carcinogenesis 1989;10:1753-1755.
53. Weddle DL, Tithoff P, Williams M, Schuller HM: Beta-adrenergic growth regulation of humancancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis 2001;22:473-479.
54. Wu WK, Wong HP, Luo SW, Chan K, Huang FY, Hui MK, Lam EK, Shin VY, Ye YN, Yang YH,Cho CH: 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates coloncancer growth via beta-adrenoceptors. Cancer Res 2005;65:5272-5277.
55. Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, Meier CR: Calcium-channel blockers and riskof cancer. Lancet 1997;349:525-528.
56. Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ: Do calcium channel block-ers increase the risk of cancer? Am J Hypertens 1996;9:695-699.
57. Algazi M, Plu-Bureau G, Flahault A, Dondon MG, Le MG: Could treatments with beta-blockersbe associated with a reduction in cancer risk? Rev Epidemiol Sante Publique 2004;52:53-65.
58. Heusch WL, Maneckjee R: Signalling pathways involved in nicotine regulation of apoptosis ofhuman lung cancer cells. Carcinogenesis 1998;19:551-556.
59. Mai H, May WS, Gao F, Jin Z, Deng X: A functional role for nicotine in Bcl2 phosphorylation andsuppression of apoptosis. J Biol Chem 2003;278:1886-1891.
60. Jin Z, Gao F, Flagg T, Deng X: Nicotine induces multi-site phosphorylation of Bad in associationwith suppression of apoptosis. J Biol Chem 2004;279:23837-23844.
61. Xin M, Deng X: Nicotine inactivation of the proapoptotic function of Bax through phosphoryla-tion. J Biol Chem 2005;280:10781-1079.
62. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA:Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normalhuman airway epithelial cells. J Clin Invest 2003;111:81-90.
63. Yamamura M, Amano Y, Sakagami H, Yamanaka Y, Nishimoto Y, Yoshida H, Yamaguchi M, Ohata H,Momose K, Takeda M: Calcium mobilization during nicotine-induced cell death in human gliomaand glioblastoma cell lines. Anticancer Res 1998;18:2499-2502.
64. Yoshida H, Sakagami H, Yamanaka Y, Amano Y, Yamaguchi M, Yamamura M, Fukuchi K, Gomi K,Ohata H, Momose K, Takeda M: Induction of DNA fragmentation by nicotine in human myeloge-nous leukemic cell lines. Anticancer Res 1998;18:2507-2511.
65. Yoshida H, Sakagami H, Yamanaka Y, Amano Y, Yamaguchi M, Yamamura M, Fukuchi K, Gomi K,Ohata H, Momose K, Takeda M: Induction of DNA fragmentation by nicotine in human myeloge-nous leukemic cell lines. Anticancer Res 1998;18:2507-2511.
66. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst1990;82:4-6.
67. Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP: A novel angiogenic pathway mediated bynon-neuronal nicotinic acetylcholine receptors. J Clin Invest 2002;110:527-536.
68. Liu ES, Ye YN, Shin VY, Yuen ST, Leung SY, Wong BC, Cho CH: Cigarette smoke exposure increasesulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis 2003;24:1407-1413.
69. Shin VY, Wu WK, Chu KM, Wong HP, Lam EK, Tai EK, Koo MW, Cho CH: Nicotine inducescyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Mol Cancer Res 2005;3:607-615.
70. Savage SM, Donaldson LA, Cherian S, Chilukuri R, White VA, Sopori ML: Effects of cigarettesmoke on the immune response. II. Chronic exposure to cigarette smoke inhibits surfaceimmunoglobulin-mediated responses in B cells. Toxicol Appl Pharmacol 1991;111:523-529.
71. Geng Y, Savage SM, Johnson LJ, Seagrave J, Sopori ML: Effects of nicotine on the immuneresponse. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction inlymphocytes. Toxicol Appl Pharmacol 1995;135:268-278.
72. Kalra R, Singh SP, Savage SM, Finch GL, Sopori ML: Effects of cigarette smoke on immuneresponse: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells anddepletes IP3-sensitive Ca(2+) stores. J Pharmacol Exp Ther 2000;293:166-171.
73. Basta PV, Basham KB, Ross WP, Brust ME, Navarro HA: Gestational nicotine exposure alone orin combination with ethanol down-modulates offspring immune function. Int J Immunopharmacol2000;22:159-169.
74. Nouri-Shirazi M, Guinet E: Evidence for the immunosuppressive role of nicotine on human den-dritic cell functions. Immunology 2003;109:365-373.
75. Sugano N, Shimada K, Ito K, Murai S: Nicotine inhibits the production of inflammatory media-tors in U937 cells through modulation of nuclear factor-kappaB activation. Biochem Biophys ResCommun 1998;252:25-28.